DocuSign's 21 CFR Part 11 Life Sciences Modules support compliance with FDA and GxP regulations, enabling secure, auditable electronic signatures for healthcare and life sciences. Used in clinical trials and R&D, the solution offers centralized controls, automated workflows, strong encryption (AES-256), and audit trails. With over 1M customers globally, it integrates with Salesforce, SAP, Oracle, and more. Customers like Boehringer Ingelheim and Boston Scientific report faster turnaround times (3 days vs. 13), 88% error reduction, and multimillion-dollar savings in clinical, regulatory, and distribution processes.

Join for free to read